Human polymorphonuclear neutrophils (PMN) produce and inactivate platelet-activating factor, leukotriene B 4, and 5- hydroxyicosatetraenoate. These lipid mediators stimulate cells by conventional transduction pathways, i.e., by binding to their respective, N-protein coupled, plasma membrane receptors. Compared to other similarly acting stimuli (e.g., peptide hormones), however, the mediators have radically different physiochemical properties and in vivo toxicities. Thus, cells may process and respond to the mediators using novel mechanisms. Our progress supports this notion and suggests the following models. First, the mediators bypass their cell surface receptors to penetrate plasmalemma and reach their intracellular sites of metabolism. Their passage through cytosol may involve soluble transfer proteins. Second, the mediators stimulate their own synthesis while inhibiting each others metabolic inactivation. These effects promote mediator accumulation and bioaction. Concurrently, the mediators rapidly promote mediator accumulation and bioaction. Concurrently, the mediators rapidly (<15 sec) inactivate their receptors. This effect limits the cell's response. The two models make a series of predictions which we will test in PMN and HL-60 cells. Proposed experiments employ chemical, biochemical, and enzymatic techniques to prepare and measure production of diverse cellular phospholipids and arachidonate metabolites; density gradient techniques to isolate PMN organelles; binding assays to measure mediator receptors; and several bioassays to evaluate mediator actions and receptor function. Experiments will examine: mediator/mediator receptor internalization and other movements; binding and transport of mediators by cytosolic carrier proteins; mediator metabolism; subcellular locations, substrate specificities, and activities of enzymes inactivating the mediators; the bioactions of recently defined mediators (e.g., alkenyl acetyl glycerophosphoethanolamine); and function of the receptors as they bind their ligand and their patent cells become mediator-unresponsive. Our studies may expand existing concepts on receptors, stimulus transduction, and ligand processing. Furthermore, the mediators as well as PMN are crucial for host defenses but also contributors to inflammatory, allergic, bronchospastic, anaphylactic, and shock reactions. This proposal, then, is relevant to cellular physiology, pharmacology, hematology, pulmonary diseases, immunology, and clinical medicine.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL027799-12
Application #
3339331
Study Section
Pathology A Study Section (PTHA)
Project Start
1981-08-01
Project End
1994-07-31
Budget Start
1992-08-01
Budget End
1993-07-31
Support Year
12
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Wake Forest University Health Sciences
Department
Type
Schools of Medicine
DUNS #
041418799
City
Winston-Salem
State
NC
Country
United States
Zip Code
27106
O'Flaherty, J T; Kuroki, M; Nixon, A B et al. (1996) 5-Oxo-eicosanoids and hematopoietic cytokines cooperate in stimulating neutrophil function and the mitogen-activated protein kinase pathway. J Biol Chem 271:17821-8
O'Flaherty, J T; Kuroki, M; Nixon, A B et al. (1996) 5-Oxo-eicosatetraenoate is a broadly active, eosinophil-selective stimulus for human granulocytes. J Immunol 157:336-42
Sozzani, S; Zhou, D; Locati, M et al. (1996) Stimulating properties of 5-oxo-eicosanoids for human monocytes: synergism with monocyte chemotactic protein-1 and -3. J Immunol 157:4664-71
O'Flaherty, J T; Tessner, T; Greene, D et al. (1994) Comparison of 1-O-alkyl-, 1-O-alk-1'-enyl-, and 1-O-acyl-2-acetyl-sn-glycero-3-phosphoethanolamines and -3-phosphocholines as agonists of the platelet-activating factor family. Biochim Biophys Acta 1210:209-16
O'Flaherty, J T; Rossi, A G (1993) 5-hydroxyicosatetraenoate stimulates neutrophils by a stereospecific, G protein-linked mechanism. J Biol Chem 268:14708-14
O'Flaherty, J T; Cordes, J; Redman, J et al. (1993) 5-Oxo-eicosatetraenoate, a potent human neutrophil stimulus. Biochem Biophys Res Commun 192:129-34
O'Flaherty, J T; Jacobson, D P; Redman, J F (1992) Regulation of platelet-activating-factor receptors and the desensitization response in polymorphonuclear neutrophils. Biochem J 288 ( Pt 1):241-8
Sozzani, S; Agwu, D E; McCall, C E et al. (1992) Propranolol, a phosphatidate phosphohydrolase inhibitor, also inhibits protein kinase C. J Biol Chem 267:20481-8
O'Flaherty, J T; Rossi, A G; Redman, J F et al. (1991) Tumor necrosis factor-alpha regulates expression of receptors for formyl-methionyl-leucyl-phenylalanine, leukotriene B4, and platelet-activating factor. Dissociation from priming in human polymorphonuclear neutrophils. J Immunol 147:3842-7
Rossi, A G; O'Flaherty, J T (1991) Bioactions of 5-hydroxyicosatetraenoate and its interaction with platelet-activating factor. Lipids 26:1184-8

Showing the most recent 10 out of 38 publications